IRIS
PECCI, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.493
AS - Asia 5.956
EU - Europa 4.814
SA - Sud America 786
Continente sconosciuto - Info sul continente non disponibili 502
AF - Africa 187
OC - Oceania 15
Totale 21.753
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.067
CN - Cina 2.774
SG - Singapore 1.273
IE - Irlanda 985
IT - Italia 855
HK - Hong Kong 660
BR - Brasile 576
DE - Germania 520
VN - Vietnam 507
FI - Finlandia 506
RU - Federazione Russa 461
UA - Ucraina 408
FR - Francia 269
GB - Regno Unito 264
SE - Svezia 260
CA - Canada 198
BD - Bangladesh 159
IN - India 135
AR - Argentina 79
ZA - Sudafrica 69
TR - Turchia 66
NL - Olanda 65
IQ - Iraq 58
MX - Messico 55
JP - Giappone 52
EC - Ecuador 34
BE - Belgio 32
ES - Italia 31
ID - Indonesia 29
PK - Pakistan 29
CO - Colombia 26
IL - Israele 26
CR - Costa Rica 25
PL - Polonia 25
MY - Malesia 24
MA - Marocco 23
HN - Honduras 20
CZ - Repubblica Ceca 19
SV - El Salvador 19
SA - Arabia Saudita 18
VE - Venezuela 17
AT - Austria 16
RO - Romania 16
SC - Seychelles 16
TN - Tunisia 16
CW - ???statistics.table.value.countryCode.CW??? 15
PH - Filippine 15
TT - Trinidad e Tobago 15
CH - Svizzera 14
CL - Cile 14
GT - Guatemala 14
NI - Nicaragua 14
JM - Giamaica 13
UZ - Uzbekistan 13
AZ - Azerbaigian 12
DZ - Algeria 12
EG - Egitto 12
IR - Iran 12
KR - Corea 12
JO - Giordania 11
PA - Panama 11
PE - Perù 11
PR - Porto Rico 11
PY - Paraguay 11
TH - Thailandia 11
BO - Bolivia 10
KE - Kenya 10
AU - Australia 8
BH - Bahrain 8
MU - Mauritius 8
RS - Serbia 8
UY - Uruguay 8
DK - Danimarca 7
KG - Kirghizistan 7
SK - Slovacchia (Repubblica Slovacca) 7
AE - Emirati Arabi Uniti 6
DO - Repubblica Dominicana 6
GP - Guadalupe 6
NZ - Nuova Zelanda 6
ET - Etiopia 5
HU - Ungheria 5
OM - Oman 5
PS - Palestinian Territory 5
PT - Portogallo 5
BB - Barbados 4
BG - Bulgaria 4
BS - Bahamas 4
EE - Estonia 4
EU - Europa 4
GR - Grecia 4
KW - Kuwait 4
LB - Libano 4
LT - Lituania 4
MD - Moldavia 4
AL - Albania 3
GE - Georgia 3
HR - Croazia 3
KZ - Kazakistan 3
LK - Sri Lanka 3
SY - Repubblica araba siriana 3
Totale 21.223
Salva come PNG Salva come JPEG
Città #
San Jose 1.052
Dublin 981
Chandler 835
Ashburn 796
Singapore 668
Hong Kong 645
Dallas 592
Jacksonville 574
Council Bluffs 564
Nanjing 555
Beijing 452
Boardman 280
Nanchang 217
Munich 208
Princeton 204
Wilmington 197
Los Angeles 188
Ho Chi Minh City 187
Lawrence 180
Changsha 177
Lauterbourg 177
Medford 164
Shenyang 159
Hebei 155
Helsinki 150
Milan 149
New York 134
Jiaxing 127
Hanoi 121
Ann Arbor 102
Buffalo 99
Pavia 95
Santa Clara 94
Tianjin 92
Shanghai 83
Hangzhou 79
Moscow 75
São Paulo 66
Turku 66
Redondo Beach 64
Johannesburg 58
Woodbridge 54
Houston 52
Orem 52
Rome 52
Montreal 46
Brooklyn 44
Tokyo 42
Atlanta 40
Toronto 38
Verona 38
Columbus 35
Chennai 34
Chicago 34
Phoenix 34
Seattle 33
Denver 32
Naples 32
Norwalk 32
Frankfurt am Main 31
London 30
Ankara 29
Guangzhou 29
North Bergen 27
The Dalles 27
Brussels 26
Da Nang 24
Mexico City 24
Fairfield 23
Nuremberg 23
Pune 23
Baghdad 21
Zhengzhou 21
Biên Hòa 19
Boston 19
San Francisco 19
San José 19
Amsterdam 18
Brasília 18
Falkenstein 18
San Salvador 17
Warsaw 17
Auburn Hills 16
Falls Church 16
Haiphong 16
Ningbo 16
Jinan 15
Las Vegas 15
Manchester 15
Stockholm 15
Willemstad 15
Bari 14
Curitiba 13
Florence 13
Rio de Janeiro 13
Secaucus 13
Turin 13
Belo Horizonte 12
Des Moines 12
Guatemala City 12
Totale 13.361
Salva come PNG Salva come JPEG
Nome #
Impaired respiratory function reduces haemoglobin oxygen affinity in COVID-19 378
Anemia in patients with Covid-19: pathogenesis and clinical significance 306
MYH9-Related Disorders. 293
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 201
NOVEL PERSPECTIVES IN GENOTYPE-PHENOTYPE CORRELATIONS IN MYH9-RELATED DISEASE: NO LONGER JUST A MATTER OF HEAD OR TAIL 180
A combination regimen of idarubicin and cytosine arabinoside for patients with high-risk myelodysplastic syndromes 177
Correction to: Anemia in patients with Covid-19: pathogenesis and clinical significance (Clinical and Experimental Medicine, (2021), 10.1007/s10238-020-00679-4) 174
A qualitative and quantitative cytochemical assay of dihydrofolate reductase in megakariocytes of patients with 5q-syndrome. 169
Adhesive receptors, extracellular proteins and myosin IIA orchestrate proplatelet formation by human megakaryocytes. 169
Correction to: Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy (Internal and Emergency Medicine, (2021), 16, 5, (1141-1152), 10.1007/s11739-020-02550-6) 166
A case of phagocytic multiple myeloma 164
β-1 tubulin R307H SNP alters microtubule dynamics and affects severity of a hereditary thrombocytopenia. 164
Patients with Lemierre syndrome have a high risk of new thromboembolic complications, clinical sequelae and death: an analysis of 712 cases 162
Clinical and pathogenetic characterization of ETV6-related thrombocytopenia (ETV6-RT), an inherited thrombocytopenia (IT) predisposing to childhood acute lymphoblastic leukemia (ALL) 157
Altered cytoskeleton organization in platelets from patients with MYH9-related disease. 156
5′UTR point substitutions and N-terminal truncating mutations of ANKRD26 in acute myeloid leukemia 155
Impact of COVID-19 on liver function: results from an internal medicine unit in Northern Italy 152
Cochlear implantation is safe and effective in patients with MYH9-related disease. 151
A G to C transversion at the last nucleotide of exon 25 of the MYH9 gene results in a missense mutation rather than in a splicing defect. 151
Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia 151
Cord blood-derived hematopoietic progenitor cells: in vitro response to hematopoietic growth factors and their recruitment into the S-phase of the cell cycle. 151
ACTN1-related thrombocytopenia: identification of novel families for phenotypic characterization. 150
Germline mutations in ETV6 are associated with thrombocytopenia, red cell macrocytosis and predisposition to lymphoblastic leukemia 149
Bleeding risk of surgery and its prevention in patients with inherited platelet disorders. The Surgery in Platelet disorders And Therapeutic Approach (SPATA) study 148
Ex vivo immunosuppressive effects of mesenchymal stem cells on Crohn's disease mucosal T cells are largely dependent on indoleamine 2,3-dioxygenase activity and cell-cell contact 148
A MONOALLELIC LOSS-FUNCTION MUTATION IN THE THROMBOPOIETIN (THPO) GENE IS RESPONSIBLE FOR A NEW FORM OF INHERITED THROMBOCYTOPENIA (IT) 145
BERNARD SOULIER SYNDROME IN A PATIENT AFFECTED BY KLINEFELTER DISEASE: NOVEL A386G HOMOZYGOUS MUTATION OF GPIB alpha GENE WITH ANOMALOUS BEHAVIOUR 144
Autosomal dominant thrombocytopenias with reduced expression of glycoprotein Ia 142
Endogenous fibronectin modulates collagen-dependent spreading and proplatelet formation by human megakaryocytes 141
Spectrum of the mutations in Bernard-Soulier syndrome. 139
Both haploinsufficiency and dominant negative effects are responsible for abnormalities of patiens with MHY9-related disease. 138
A case of metastatic malignant melanoma with bone marrow involvement. 137
Ubiquitin/proteasome-rich particulate cytoplasmic structures (PaCSs) in the platelets and megakaryocytes of ANKRD26-related thrombo-cytopenia. 137
Cell cycle distribution of cord blood-derived haematopoietic progenitor cells and their recruitment into the S-phase of the cell cycle 137
3D silk bone marrow model: a promising tool to test efficacy of new biomimetic drugs on platelet production 137
Immunocytochemistry for the heavy chain of the non-muscle myosin IIA as a diagnostic tool for MYH9-related disorders. 136
Dihydrofolate reductase activity in the erythroblasts of patients with 5q-syndrome. 136
Chaperone molecules concentrate together with the ubiquitin–proteasome system inside particulate cytoplasmic structures: possible role in metabolism of misfolded proteins 136
Alteration of Liver Enzymes Is a Feature of the Myh9-Related Disease Syndrome. 136
THE D1424N AND R1933X MUTATIONS OF MYH9 CAUSE THROMBOCYTOPENIA THROUGH LOSS OF REGULATION OF PROPLATELET FORMATION BY TYPE I COLLAGEN. 136
A A386G biallelic GPIb alpha gene mutation with anomalous behavior: a new mechanism suggested for Bernard-Soulier syndrome pathogenesis. 135
Clinical and laboratory features of 103 patients from 42 Italian families with inherited thrombocytopenia derived from the monoallelic Ala156Val mutation of GPIb{alpha} (Bolzano mutation). 133
The myelodysplastic syndromes: predictive value of eight prognostic systems in 143 cases from a single institution. 132
A new form of inherited thrombocytopenia due to monoallelic loss of function mutation in the thrombopoietin gene 132
Clinical and genetic aspects Bernard-Soulier syndrome: searching for genotype/phenotype correlations. 132
Bone marrow necrosis in acute lymphoblastic leukemia. 131
Platelet diameters in inherited thrombocytopenias: analysis of 376 patients with all known disorders. 129
Thrombopoietin is not uniquely responsible for thrombocytosis in inflammatory disorders 129
A therapy-related myelodysplastic syndrome with unusual features in a patient treated for acute promyelocytic leukemia. 127
A novel mutation in gp1bb reveals the role of the cytoplasmic domain of gpibβ in the pathophysiology of bernard‐soulier syndrome and gpib‐ix complex assembly 125
Circulating CD34+, CD133+, and vascular endothelial growth factor receptor 2-positive endothelial progenitor cells in myelofibrosis with myeloid metaplasia. 124
Inherited thrombocytopenias. The evolving spectrum. 123
Clinical and pathogenic features of ETV6-related thrombocytopenia with predisposition to acute lymphoblastic leukemia 123
Exome sequencing in 116 patients with inherited thrombocytopenia that remained of unknown origin after systematic phenotype-driven diagnostic workup 122
Particulate cytoplasmic structures with high concentration of ubiquitin-proteasome accumulate in myeloid neoplasms 122
X-linked thrombocytopenia with thalassemia: Clinical and biological features of a second family 122
Recent advances in the understanding and management of MYH9-related inherited thrombocytopenias. 121
Expression, activation, and subcellular localization of the Rap1, GTPase in human cord blood-derived megakaryocytes. 120
Thrombopoietin mutation in congenital amegakaryocytic thrombocytopenia treatable with romiplostim 119
NOVEL RUNX1 MUTATIONS IN FAMILIES WITH INHERITED THROMBOCYTOPENIA 119
MYH9-related disease: five novel mutations expanding the spectrum of causative mutations and confirming genotype/phenotype correlations. 118
Lessons in platelet production from inherited thrombocytopenias. 118
The Case. Proteinuria and low platelet count. 116
Diagnostic and clinical relevance of the number of circulating CD34+ cells in myelofibrosis with myeloid metaplasia. 116
Eltrombopag in preparation for surgery in patients with severe MYH9-related thrombocytopenia 116
Transfection of the mutant MYH9 cDNA reproduces the most typical cellular phenotype of MYH9-related disease in different cell lines. 114
Mutations responsible for MYH9-related thrombocytopenia impair SDF-1-driven migration of megakaryoblastic cells. 113
Application of a diagnostic algorithm to 50 consecutive patients with inherited thrombocytopenias 113
MYH9 related disease: four novel mutations of the tail domain of myosin-9 correlating with a mild clinical phenotype. 113
Eltrombopag for the treatment of inherited thrombocytopenias: A phase II clinical trial 113
Common laboratory tests and their correlation with the clinical presentation and prognosis of Lemierre syndrome 112
Expression of p53, bcl-2 and ras oncoproteins in acute leukemias and myelodysplastic syndromes 112
R705H mutation of MYH9 is associated with MYH9-related disease and not only with non-syndromic deafness DFNA17. 110
Application of a diagnostic algorithm for inherited thrombocytopenias to 46 consecutive patients. 110
Efficacy and safety of factor VIII inhibitor by-passing activity (FEIBA) in high thrombotic risk patients with acquired haemophilia (AH) Efficacy and safety of factor VIII inhibitor by-passing activity (FEIBA) in high thrombotic risk patients with acquired haemophilia (AH) 109
Short-term eltrombopag for surgical preparation of a patient with inherited thrombocytopenia deriving from MYH9 mutation. 109
BERNARD SOULIER SYNDROME IN A PATIENT AFFECTED BY KLINEFELTER DISEASE: NOVEL A386G HOMOZYGOUS MUTATION OF GPIB alpha GENE WITH ANOMALOUS BEHAVIOUR 109
Dysregulation of oncogenic factors by GFI1B p32: investigation of a novel GFI1B germline mutation 109
Genetics, clinical and pathological features of glomerulonephritis associated with mutations of nonmuscle myosin IIA (Fechtner syndrome) 108
Validation of the ISTH/SSC bleeding assessment tool for inherited platelet disorders: A communication from the Platelet Physiology SSC 108
Expression, activation, and subcellular localization of the Rap1 GTPase in cord blood-derived human megakaryocytes. 107
Low-dose thalidomide ameliorates cytopenia and splenomegaly in myelofibrosis with myeloid metaplasia: a phase II clinical trial. 107
Expression, activation, and subcellular localization of the Rap1, GTPase in human cord blood-derived megakaryocytes 107
Von Willebrand Factor and GPIb regulates proplatelets formation by human megakaryocytes. 105
The D1424N and R1933X mutations of MYH9 result in an altered proplatelet formation by human megakaryocytes 105
Expression of dipeptidylaminopeptidase IV/CD26 in peripheral blood lymphocytes of hemophilic subjects. 105
Heavy chain myosin 9-related disease (MYH9-RD): neutrophil inclusions of myosin-9 as a pathognomonic sign of the disorder. 104
ETV6-RELATED THROMBOCYTOPENIA (ETV6-RT): CLINICAL AND PATHOGENETIC CHARACTERIZATION OF AN INHERITED THROMBOCYTOPENIA (IT) PREDISPOSING TO CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) 104
ACTN1 mutations lead to a benign form of platelet macrocytosis not always associated with thrombocytopenia 103
The ISTH bleeding assessment tool as predictor of bleeding events in inherited platelet disorders: Communication from the ISTH SSC Subcommittee on Platelet Physiology 103
Dihydrofolate reductase activity in the erythroblasts of patients with 5q- syndrome. 102
Cord blood in vitro expanded CD41+ cells: Identification novel components of megakaryocytopoiesis 102
The european hematology association roadmap for european hematology research: A consensus document 102
Platelet size distinguishes between inherited macrothrombocytopenias and immune thrombocytopenia. 101
Clinical and biological effects of treatment with amifostine in myelodysplastic syndromes 101
ANKRD26-related thrombocytopenia and myeloid malignancies 101
Dissecting clinical findings: platelet defects segregate independently of deafness and cataract in a family affected by an apparent syndromic form of macrothrombocytopenia. 101
Apoptosis in relation to CD34 antigen expression in normal and myelodysplastic bone marrow. 100
Expression, activation and subcellular localization of the Rap1 GTPase in human cord blood-derived megakaryocytes 100
MYH9-related disease: a novel prognostic model to predict the clinical evolution of the disease based on genotype-phenotype correlations. 100
Totale 13.425
Salva come PNG Salva come JPEG
Categoria #
all - tutte 92.958
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 92.958
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022815 0 0 0 0 38 29 26 47 49 39 122 465
2022/20232.484 265 165 14 215 237 250 2 125 1.097 12 67 35
2023/20241.020 96 166 25 81 161 237 55 54 8 50 45 42
2024/20252.960 70 235 77 96 68 197 201 238 643 100 341 694
2025/20267.201 498 470 882 841 747 307 1.381 364 608 502 356 245
2026/20272.698 176 506 596 957 463 0 0 0 0 0 0 0
Totale 21.753